No record found


* Returns not adjusted for payouts
Company Profile
Highnoon Laboratories Limited was incorporated in Pakistan under the Companies Act, 2017. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.
Dr. Adeel Abbas Haideri | CEO |
Mr. Tausif Ahmad Khan | Chairman |
Ms. Mahnoor Ather | Company Secretary |
Corplink (Pvt) Ltd. Wings Arcade 1 K Commercial, Model Town, Lahore.
EY Ford Rhodes Chartered Accountants.
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 27, 2022 | Financial Results for the Quarter Ended September 30,2022 | View PDF |
Aug 31, 2022 | Transmission of Quarterly Report for the period ended June 30,2022 | View PDF |
Aug 15, 2022 | Financial Results for the half year ended June 30,2022 | View PDF |
Apr 18, 2022 | Financial Results for the Quarter ended March 31,2022 | View PDF |
Mar 29, 2022 | Transmission of Annual Report for the year ended December 31,2021 | View PDF |
Mar 16, 2022 | Financial Results for the year ended December 31,2021 | View PDF |
Oct 29, 2021 | Transmission of Quarterly Report for the period ended September 30,2021 | View PDF |
Oct 22, 2021 | Financial Results for the Quarter ended September 30,2021 | View PDF |
Aug 12, 2021 | Financial Results for 2nd Quarter | View PDF |
Apr 29, 2021 | Transmission of Quarterly Report for the Period Ended 31 March 2021 | View PDF |
Date | Title | Document |
---|---|---|
Dec 12, 2022 | Board Meeting Other Than Financial Results | View |
Oct 20, 2022 | Board Meeting | View PDF |
Aug 5, 2022 | Board Meeting | View PDF |
Apr 18, 2022 | Shareholders' Resolution at the 39th Annual General Meeting of the Company | View PDF |
Apr 11, 2022 | Board Meeting | View PDF |
Mar 28, 2022 | Notice of Annual General Meeting | View PDF |
Mar 28, 2022 | Notice of Annual General Meeting | View PDF |
Mar 9, 2022 | Board Meeting for Approval of Annual Accounts | View PDF |
Oct 15, 2021 | Board Meeting for Approval of Quarterly Financials | View PDF |
Sep 2, 2021 | Board Meeting for appointment of CEO | View PDF |
Date | Title | Document |
---|---|---|
Jan 20, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jan 17, 2023 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 19, 2022 | Resignation of Director | View |
Dec 12, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Dec 2, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Nov 23, 2022 | Change of Company Secretary | View |
Oct 31, 2022 | Transmission of Quarterly Report | View PDF |
Sep 1, 2022 | Material Information | View PDF |
Jun 16, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Jun 15, 2022 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED | View |
Financials
All numbers in thousands (000's) except EPS
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Sales | 13,000,780 | 10,697,634 | 9,047,693 | 7,503,101 |
Profit after Taxation | 1,808,033 | 1,420,736 | 971,013 | 725,891 |
EPS | 47.48 | 41.04 | 28.05 | 23.07 |
Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | |
---|---|---|---|---|
Sales | 4,191,865 | 4,327,695 | 3,756,034 | 3,209,577 |
Profit after Taxation | 661,814 | 559,651 | 533,700 | 377,101 |
EPS | 15.80 | 13.36 | 14.02 | 9.00 |

Ratios
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Gross Profit Margin (%) | 49.35 | 47.87 | 46.00 | 46.65 |
Net Profit Margin (%) | 13.91 | 13.28 | 10.73 | 9.67 |
EPS Growth (%) | 15.69 | 46.31 | 21.59 | (5.95) |
PEG | 0.84 | 0.32 | 0.89 | (2.53) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
March 16, 2022 3:48 PM | 31/12/2021(YR) | 200% (D) - 10% (B) | 11/04/2022 - 18/04/2022 |
March 25, 2021 4:01 PM | 31/12/2020(YR) | 150%(F) (D) - 10% (B) | 26/04/2021 - 27/04/2021 |
March 31, 2020 3:12 PM | 31/12/2019(YR) | 130% (D) - 10% (B) | 05/05/2020 - 12/05/2020 |
March 29, 2019 4:20 PM | 31/12/2018(YR) | 130%(F) (D) - 10% (B) | 23/04/2019 - 29/04/2019 |
March 9, 2018 3:55 PM | 31/12/2017(YR) | 100% (D) - 12% (B) | 12/04/2018 - 23/04/2018 |
March 16, 2017 3:45 PM | 31/12/2016(YR) | 85% (D) - 12% (B) | 21/04/2017 - 27/04/2017 |
March 15, 2016 3:38 PM | 31/12/2015(YR) | 75% (D) - 12% (B) | 14/04/2016 - 22/04/2016 |
March 20, 2015 3:49 PM | 31/12/2014(YR) | 65% (D) - 12% (B) | 17/04/2015 - 27/04/2015 |
March 18, 2014 2:49 PM | 31/12/2013(YR) | 45% (D) | 15/04/2014 - 24/04/2014 |
March 19, 2013 1:12 PM | 31/12/2012(YR) | 35% (F) (D) | 15/04/2013 - 23/04/2013 |